This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation.

This guide intends to educate clinicians and other stakeholders about the harms of using more than one substance and consideration for addressing concurrent substance use (CSU) and concurrent substance use disorders (CSUD).

This guide examines emerging and best practices for initiating medication-assisted treatment in emergency departments. It also reviews the existing literature and science of the topic, identifies gaps in knowledge, and discusses challenges of implementation.

This issue brief presents recent data on prevalence of opioid misuse & death rates in the Hispanic/Latino population; contextual factors & challenges to prevention & treatment; innovative outreach & engagement strategies to connect people to evidence-based treatment; and the importance of community voice.

This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.

This toolkit outlines the essential components for supportive housing services and programs for people living with mental illness disorders. It discusses how to develop and integrate evidence-based programs in mental health systems. The toolkit includes eight booklets on program development.

This toolkit gives practice principles for integrated treatment for mental illness, substance use disorders, or both, and offers advice from successful programs. The toolkit includes a brochure, a PowerPoint presentation, and a introductory video.

This toolkit offers tools to implement the evidence-based practice of Assertive Community Treatment (ACT). ACT offers customized, community-based services for people living with mental illness. The toolkit includes a brochure (English, Spanish), a PowerPoint presentation, and an introductory video.